| scholarly article | Q13442814 |
| P50 | author | Clay F. Semenkovich | Q42738655 |
| Babak Razani | Q56835760 | ||
| Irfan J Lodhi | Q57370057 | ||
| Trey Coleman | Q114301141 | ||
| P2093 | author name string | Jeffrey E Saffitz | |
| Daniel P Kelly | |||
| Gerald W Dorn | |||
| Colin G Nichols | |||
| Haixia Zhang | |||
| P Christian Schulze | |||
| Attila Kovacs | |||
| Joel D Schilling | |||
| Veli K Topkara | |||
| Chu Feng | |||
| John Verbsky | |||
| P2860 | cites work | Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation | Q24295025 |
| The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure | Q24299296 | ||
| Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart | Q24323983 | ||
| Kir6.2 is required for adaptation to stress | Q24538695 | ||
| Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting | Q24563197 | ||
| Identification of a physiologically relevant endogenous ligand for PPARalpha in liver | Q24653691 | ||
| How highly charged anionic lipids bind and regulate ion channels | Q24656180 | ||
| Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor | Q28139202 | ||
| Tenascin-C in development and disease: gene regulation and cell function | Q28139238 | ||
| Structural and functional organization of the animal fatty acid synthase | Q28190255 | ||
| Cardiac excitation-contraction coupling | Q28216347 | ||
| ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome | Q28280671 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP | Q28591399 | ||
| Modulation of voltage-dependent Ca channel current by arachidonic acid and other long-chain fatty acids in rabbit intestinal smooth muscle | Q30433467 | ||
| Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice | Q30488460 | ||
| De novo lipogenesis in humans: metabolic and regulatory aspects | Q33655979 | ||
| Regulation of the fatty acid synthase promoter by insulin | Q33866090 | ||
| Cardiac fatty acid uptake and transport in health and disease | Q33869970 | ||
| Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis | Q34004031 | ||
| The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart | Q34022068 | ||
| The L-type calcium channel in the heart: the beat goes on | Q34160273 | ||
| Cardiac mechanotransduction: from sensing to disease and treatment | Q34243174 | ||
| The effect of cardiac resynchronization on morbidity and mortality in heart failure | Q34400885 | ||
| Caveolae: from cell biology to animal physiology | Q34838611 | ||
| Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero | Q35142911 | ||
| CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo | Q35159705 | ||
| Fatty acid homeostasis in the normoxic and ischemic heart | Q35531455 | ||
| Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer | Q35572195 | ||
| Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? | Q35792113 | ||
| Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. | Q35921527 | ||
| A novel mouse model of lipotoxic cardiomyopathy | Q36016938 | ||
| Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse | Q36944568 | ||
| Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels | Q37020705 | ||
| Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. | Q37056105 | ||
| Toward biologically targeted therapy of calcium cycling defects in heart failure | Q37082359 | ||
| Differential modulation of L-type calcium channel subunits by oleate | Q37092809 | ||
| The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload | Q37114848 | ||
| Lysophosphatidyl choline modulates mechanosensitive L-type Ca2+ current in circular smooth muscle cells from human jejunum | Q37162450 | ||
| Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. | Q37170829 | ||
| Polyunsaturated fatty acid modulation of voltage-gated ion channels | Q37284810 | ||
| SREBPs: physiology and pathophysiology of the SREBP family | Q37368394 | ||
| Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. | Q37369799 | ||
| Rodent models of diabetic cardiomyopathy. | Q37591072 | ||
| Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy | Q37596176 | ||
| Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus | Q39035715 | ||
| Myocardial metabolism of fatty acids | Q40331547 | ||
| Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation | Q40483909 | ||
| Differentiation-dependent expression of cardiac delta-CaMKII isoforms | Q41069625 | ||
| Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae | Q41358613 | ||
| The cellular and molecular response of cardiac myocytes to mechanical stress. | Q41388060 | ||
| Regulation of fatty acid synthase (FAS). | Q41646396 | ||
| Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium | Q42464471 | ||
| RETRACTED: L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. | Q42597255 | ||
| Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents | Q42927715 | ||
| CaMKII and a failing strategy for growth in heart | Q43140407 | ||
| Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities | Q43678714 | ||
| A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi | Q43816422 | ||
| Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy | Q44123766 | ||
| Remodeling of excitation-contraction coupling in transgenic mice expressing ATP-insensitive sarcolemmal KATP channels | Q44680736 | ||
| LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice | Q46383286 | ||
| "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis | Q46626411 | ||
| Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP). | Q46649606 | ||
| Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles | Q47350584 | ||
| Alterations of gene expression in failing myocardium following left ventricular assist device support | Q47806965 | ||
| Involvement of fatty acid synthase in axonal development in mouse embryos. | Q47822527 | ||
| Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. | Q51578105 | ||
| Klf2 is an essential regulator of vascular hemodynamic forces in vivo. | Q52000298 | ||
| Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. | Q53593992 | ||
| Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. | Q54034693 | ||
| Mechanisms for association of Ca2+/calmodulin-dependent protein kinase II with lipid rafts | Q57359506 | ||
| Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor | Q57373885 | ||
| Calmodulin kinase II inhibition protects against structural heart disease | Q59975125 | ||
| Regulation of Fatty Acid Utilization in Isolated Perfused Rat Hearts | Q69637537 | ||
| Effect of arachidonic acid on the L-type calcium current in frog cardiac myocytes | Q71335668 | ||
| In Vivo Echocardiographic Detection of Enhanced Left Ventricular Function in Gene-Targeted Mice With Phospholamban Deficiency | Q71974396 | ||
| Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice | Q72101575 | ||
| Diabetic cardiomyopathy | Q72189534 | ||
| Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy | Q72554854 | ||
| Glucose and fatty acid metabolism in the isolated working mouse heart | Q73071219 | ||
| Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice | Q74519768 | ||
| IMPORTANCE OF FATTY ACID IN MYOCARDIAL METABOLISM | Q77127304 | ||
| CaM kinase augments cardiac L-type Ca2+ current: a cellular mechanism for long Q-T arrhythmias | Q77855621 | ||
| Yin and Yang of myocardial transforming growth factor-beta1: timing is everything | Q81752705 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 30949-30961 | |
| P577 | publication date | 2011-07-08 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Fatty acid synthase modulates homeostatic responses to myocardial stress | |
| P478 | volume | 286 |
| Q90425451 | ABCC9-related Intellectual disability Myopathy Syndrome is a KATP channelopathy with loss-of-function mutations in ABCC9 |
| Q55401962 | Actionable Metabolic Pathways in Heart Failure and Cancer—Lessons From Cancer Cell Metabolism. |
| Q41825615 | Autophagy links inflammasomes to atherosclerotic progression. |
| Q94957069 | Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy |
| Q36955513 | Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels |
| Q100949984 | Common Mechanistic Pathways in Cancer and Heart Failure |
| Q35573584 | De novo lipogenesis in metabolic homeostasis: More friend than foe? |
| Q64062683 | Differential Response to Injury in Fetal and Adolescent Sheep Hearts in the Immediate Post-myocardial Infarction Period |
| Q42228725 | Electrophysiologic consequences of KATP gain of function in the heart: Conduction abnormalities in Cantu syndrome |
| Q91062686 | Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells |
| Q30855438 | Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis. |
| Q39427371 | Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy |
| Q37561020 | Fatty acid metabolism: Implications for diet, genetic variation, and disease |
| Q38715120 | Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress |
| Q28584871 | Fatty acid synthase is required for mammary gland development and milk production during lactation |
| Q90825396 | First-in-class fatty acid synthase inhibitor TVB-2640 reduces hepatic de novo lipogenesis in males with metabolic abnormalities |
| Q51738475 | Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: Evidence from fatty acid binding protein-4 and -5 knockout mice. |
| Q90018324 | High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy |
| Q48182328 | Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy |
| Q37255799 | Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis |
| Q38626650 | Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction. |
| Q36548326 | Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice |
| Q92984589 | Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension |
| Q37021871 | K(ATP) channel gain-of-function leads to increased myocardial L-type Ca(2+) current and contractility in Cantu syndrome. |
| Q38017379 | Lipid metabolism and toxicity in the heart |
| Q91446318 | Lysosomes Mediate Benefits of Intermittent Fasting in Cardiometabolic Disease: The Janitor Is the Undercover Boss |
| Q36674142 | Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. |
| Q30536570 | Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling. |
| Q90692354 | Novel role of the ER/SR Ca2+ sensor STIM1 in the regulation of cardiac metabolism |
| Q34871541 | Peroxisomal lipid synthesis regulates inflammation by sustaining neutrophil membrane phospholipid composition and viability. |
| Q36283397 | Postnatal Deletion of Fat Storage-inducing Transmembrane Protein 2 (FIT2/FITM2) Causes Lethal Enteropathy |
| Q28395122 | Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease |
| Q26822692 | Pyridine nucleotide regulation of cardiac intermediary metabolism |
| Q39388920 | We Know More Than We Can Tell About Diabetes and Vascular Disease: The 2016 Edwin Bierman Award Lecture |
Search more.